ClinicalTrials.gg
Not yet recruitingNCT06813950Updated Feb 11, 2025

Impact of a Physical Activity Program on the Health-Related Quality of Life in Pediatric Cancer Patients

An interventional study of Physical activity in Cancer and Pediatric Cancer, sponsored by Sociedad de Lucha Contra el Cáncer. Not yet recruiting at 1 site in Ecuador. Open to participants aged 8 Years to 18 Years. Per ClinicalTrials.gov, last updated 2025-02-11.

Sponsored by Sociedad de Lucha Contra el Cáncer · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Nov 2025, 1 year ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
8 Years to 18 Years
Sex
All
01

Study summary

Physical activity is essential for the health and well-being of children and adolescents. However, those living with cancer often experience reduced physical activity levels, which negatively impact their functional capacity and health-related quality of life (HRQoL). In Ecuador, data from the National Institute of Statistics and Census (2021) reveal that 20% of children engage in less than one hour of physical activity per week, highlighting the need for targeted interventions. While previous studies demonstrate that supervised exercise programs can improve physical and psychosocial health outcomes in pediatric oncology patients, no evidence exists from Ecuador to assess the effects of such programs.

This study will examine the impact of a structured physical activity program on the HRQoLof pediatric cancer patients in Quito, Ecuador. Using a case-control design, 90 participants will be randomized into two groups: an intervention group receiving a 10-week, supervised physical activity program and a control group with no exercise intervention and the programmed usual care as follow up if needed by the social worker. HRQoL surveys using a standardized instrument will be administered to all participants (those in the intervention group and those in the control group) at weeks 1, 12, and 24 to assess changes over time.

This research will address a critical public health gap by exploring how physical activity can mitigate the adverse effects of cancer treatment, improve physical and emotional health, and enhance the HRQoL in pediatric oncology patients. Findings will contribute valuable insights for integrating physical activity into pediatric oncology care in low- and middle-income countries.

Read the detailed description

This study is designed as a randomized controlled trial (RCT) to investigate the impact of a structured exercise program on the HRQoL of pediatric cancer patients. A total of 90 participants will be recruited and randomly assigned to either the intervention group or the control group.

The intervention group will participate in a 10-week structured physical activity program consisting of 120 minutes of supervised exercise per week, led by a team of physiotherapists and physical activity professionals. Meanwhile, the control group will not participate in any organized physical activity program but will continue with their usual activities.

Both groups will complete the Pediatric Quality of Life Inventory (PedsQL) surveys at baseline (week 1), midpoint (week 12), and endpoint (week 24). These surveys are designed to assess changes in participants' HRQoL over time, providing comparative insights between the two groups.

02

Conditions studied

  • Cancer
  • Pediatric Cancer

Keywords

  • physical activity
  • Quality of life
  • physical activity programs
  • lifestyle
03

In context

Neoplasms

10,818 studies on the registry are indexed under Neoplasms; 2,324 are open to participants now.

This study's planned enrollment of 80 is above the median of 60 across 7,703 interventional studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

This is the only study on the registry with Sociedad de Lucha Contra el Cáncer as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    1. Age range: Participants must be between 8 and 18 years old at the start of the study.

      1. Residency: Patients residing within the city limits of Quito, Ecuador. 3. Treatment status:
      • Patients are being evaluated or treated at Hospitals SOLCA and Baca Ortiz.
      • Patients are either currently undergoing active treatment for pediatric , or
      • Patients are in the post-treatment phase after a pediatric cancer diagnosis.
      • The volunteer or a family member that lives with the possible participant has a cellphone so the survey can be administered and answered.

Exclusion criteria

Exclusion Criteria:

    1. The presence of a malignant solid tumor which has not yet been surgically addressed.

      1. A psychiatric diagnosis of cognitive impairment. 3. A diagnosis of osteosarcoma. 4. A history of cardiac pathology. 5. The patient is in the pediatric inpatient ward or was one month prior to the enrollment phase.
      1. The patient is stationed at the pediatric intensive care unit. 7. The patient received high-dose chemotherapy with methotrexate greater than 1000 mg/m2/dose or cytarabine greater than 1 g/m2/dose in the last month.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Other
    Physical activity

    Performs supervised physical activity

    Other: Physical activity

Interventions

  • OtherPhysical activity

    The intervention group will participate in a 10-week structured physical activity program consisting of 120 minutes of supervised exercise per week, led by a team of physiotherapists and physical activity professionals. Meanwhile, the control group will not participate in any organized physical activity program but will continue with their usual activities.

06

What researchers measure

Primary outcomes

  1. Health related quality of life

    To evaluate HRQoL, the study will use the PedsQL, specifically the PedsQL 3.0 Cancer Module, a validated instrument for pediatric cancer patients aged 2 to 18 years. This module comprises 20 questions addressing physical, emotional, and social functioning, as well as cancer treatment-related symptoms. Participants will self-report their responses using a four-point Likert scale, with options ranging from "never" (0) to "almost always" (4). For example: "In the past month, how often have you felt tired?"; "In the past month, how often have you experienced pain or discomfort?".

    Time frame: oth groups will complete the Pediatric Quality of Life Inventory (PedsQL) surveys at baseline (week 1), midpoint (week 12), and endpoint (week 24). These surveys are designed to assess changes in participants' HRQoL over time, providing comparative insig

Secondary outcomes

  1. Physical activity

    Physical activity and sedentary habits will be determined using the Activity Profile - Spain - Version for Latin America. (YAP-SL), a self-report tool consisting of 15 items, will be used to gather data on physical activity levels and sedentary behaviors for a 7-day recall period

    Time frame: surveys at baseline (week 1), midpoint (week 12), and endpoint (week 24).

07

Study locations

1 site
08

References and documents

Publications

  • Varni JW, Burwinkle TM, Katz ER, Meeske K, Dickinson P. The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module. Cancer. 2002 Apr 1;94(7):2090-106. doi: 10.1002/cncr.10428. PubMed 11932914 ↗
  • Segura-Diaz JM, Barranco-Ruiz Y, Saucedo-Araujo RG, Aranda-Balboa MJ, Cadenas-Sanchez C, Migueles JH, Saint-Maurice PF, Ortega FB, Welk GJ, Herrador-Colmenero M, Chillon P, Villa-Gonzalez E. Feasibility and reliability of the Spanish version of the Youth Activity Profile questionnaire (YAP-Spain) in children and adolescents. J Sports Sci. 2021 Apr;39(7):801-807. doi: 10.1080/02640414.2020.1847488. Epub 2020 Nov 20. PubMed 33213295 ↗
  • Saint-Maurice PF, Welk GJ. Validity and Calibration of the Youth Activity Profile. PLoS One. 2015 Dec 2;10(12):e0143949. doi: 10.1371/journal.pone.0143949. eCollection 2015. PubMed 26630346 ↗
  • de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007 Sep;85(9):660-7. doi: 10.2471/blt.07.043497. PubMed 18026621 ↗
  • Riedl D, Licht T, Nickels A, Rothmund M, Rumpold G, Holzner B, Grote V, Fischer MJ, Fischmeister G. Large Improvements in Health-Related Quality of Life and Physical Fitness during Multidisciplinary Inpatient Rehabilitation for Pediatric Cancer Survivors. Cancers (Basel). 2022 Oct 4;14(19):4855. doi: 10.3390/cancers14194855. PubMed 36230777 ↗
  • Keats MR, Culos-Reed SN. A community-based physical activity program for adolescents with cancer (project TREK): program feasibility and preliminary findings. J Pediatr Hematol Oncol. 2008 Apr;30(4):272-80. doi: 10.1097/MPH.0b013e318162c476. PubMed 18391695 ↗
  • Gotte M, Taraks S, Boos J. Sports in pediatric oncology: the role(s) of physical activity for children with cancer. J Pediatr Hematol Oncol. 2014 Mar;36(2):85-90. doi: 10.1097/MPH.0000000000000101. PubMed 24390449 ↗
  • Rapti C, Dinas PC, Chryssanthopoulos C, Mila A, Philippou A. Effects of Exercise and Physical Activity Levels on Childhood Cancer: An Umbrella Review. Healthcare (Basel). 2023 Mar 10;11(6):820. doi: 10.3390/healthcare11060820. PubMed 36981477 ↗
  • Chaput JP, Willumsen J, Bull F, Chou R, Ekelund U, Firth J, Jago R, Ortega FB, Katzmarzyk PT. 2020 WHO guidelines on physical activity and sedentary behaviour for children and adolescents aged 5-17 years: summary of the evidence. Int J Behav Nutr Phys Act. 2020 Nov 26;17(1):141. doi: 10.1186/s12966-020-01037-z. PubMed 33239009 ↗
  • Zhang FF, Saltzman E, Must A, Parsons SK. Do Childhood Cancer Survivors Meet the Diet and Physical Activity Guidelines? A Review of Guidelines and Literature. Int J Child Health Nutr. 2012;1(1):44-58. doi: 10.6000/1929-4247.2012.01.01.06. Epub 2012 Sep 25. PubMed 26973721 ↗
  • Braam KI, van der Torre P, Takken T, Veening MA, van Dulmen-den Broeder E, Kaspers GJ. Physical exercise training interventions for children and young adults during and after treatment for childhood cancer. Cochrane Database Syst Rev. 2013 Apr 30;(4):CD008796. doi: 10.1002/14651858.CD008796.pub2. PubMed 23633361 ↗
  • Oficina Regional para las Américas de la Organización Mundial de la Salud. https://www.paho.org/es/temas/cancer-ninez-adolescencia#:~:text=En%20Am%C3%A9rica%20Latina%20y%20el,a%20causa%20de%20esta%20enfermedad. 2014 [cited 2024 Dec 1]. EL CÁNCER INFANTIL EN LAS AMÉRICAS. Available from: https://www.paho.org/es/temas/cancer-ninez-adolescencia#:~:text=En%20Am%C3%A9rica%20Latina%20y%20el,a%20causa%20de%20esta%20enfermedad
  • San Juan AF, Chamorro-Vina C, Mate-Munoz JL, Fernandez del Valle M, Cardona C, Hernandez M, Madero L, Perez M, Ramirez M, Lucia A. Functional capacity of children with leukemia. Int J Sports Med. 2008 Feb;29(2):163-7. doi: 10.1055/s-2007-964908. Epub 2007 Sep 18. PubMed 17879894 ↗
  • Tillmann V, Darlington AS, Eiser C, Bishop NJ, Davies HA. Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia. J Bone Miner Res. 2002 Jun;17(6):1073-80. doi: 10.1359/jbmr.2002.17.6.1073. PubMed 12054163 ↗
  • 3. INEC. Juntos para combatir el sedentarismo mediante el deporte y la actividad física. 2022. Juntos para combatir el sedentarismo mediante el deporte y la actividad física.
  • Wurz A, McLaughlin E, Lategan C, Chamorro Vina C, Grimshaw SL, Hamari L, Gotte M, Kesting S, Rossi F, van der Torre P, Guilcher GMT, McIntyre K, Culos-Reed SN. The international Pediatric Oncology Exercise Guidelines (iPOEG). Transl Behav Med. 2021 Oct 23;11(10):1915-1922. doi: 10.1093/tbm/ibab028. PubMed 34037786 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Feb 2025; primary completion for Nov 2025, 9 months later.

Of 1,981 non-industry interventional studies with no phase under Neoplasms, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 52. This study's planned 9 months is below that.

Counting every sponsor, half of 2,056 studies reached it within 29 months; a quarter within 13 and three quarters within 52.

Neoplasms covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 3, 2025
First posted
Feb 7, 2025
StartEst.
Feb 20, 2025
Primary completionEst.
Nov 2025
CompletionEst.
Dec 2025
Last update
Feb 11, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06813950
Lead sponsor
Sociedad de Lucha Contra el Cáncer
Responsible party
Gustavo Galarraga (Analyst Investigation Department, Sociedad de Lucha Contra el Cáncer del Ecuador) — Principal investigator
First posted
Feb 7, 2025
Start date
Feb 20, 2025 (estimated)
Primary completion
Nov 2025 (estimated)
Completion
Dec 2025 (estimated)
Last update
Feb 11, 2025

Study contacts

Gustavo Galárraga, MPH
Contact
gustavo.galarraga@solcaquito.org.ec
0991946128
Yunqi Yu, MPH
Contact
yu.yunqi@solcaquito.org.ec
+19142073580
Gustavo Galárraga, MPH
principal investigator · Sociedad de Lucha Contra el Cáncer

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion